Clinical Trial Update: Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating flupenthixol in individuals with schizophrenia and cocaine use has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine-related Disorders
• Schizophrenia

Drugs mentioned

• Flupenthixol (flupenthixol)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 2 | Status: COMPLETED